[NBIX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
09-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -172.36%
YoY- -207.09%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 288,900 236,600 247,900 258,500 302,400 237,100 244,100 11.90%
PBT 57,500 27,200 41,700 -57,100 83,200 38,900 38,600 30.46%
Tax 15,200 -4,900 -306,200 500 3,600 1,500 4,600 122.01%
NP 42,300 32,100 347,900 -57,600 79,600 37,400 34,000 15.69%
Tax Rate -26.43% 18.01% 734.29% - -4.33% -3.86% -11.92% -
Total Cost 246,600 204,500 -100,000 316,100 222,800 199,700 210,100 11.28%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 14.64 13.57 140.34 -22.28 26.32 15.77 13.93 3.37%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS 0.45 0.34 3.72 -0.62 0.86 0.40 0.37 13.95%
EPS Diluted 0.43 0.33 3.58 -0.62 0.81 0.39 0.35 14.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.